Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective reduction of cysteine residues in IL-17 antibodies

Selective reduction of cysteine residues in IL-17 antibodies

US Patent 11292833 · Granted Apr 5, 2022

Estimated economic value: $61,174,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bacterial ATP synthase binding domain2013
Bacterial ATP synthase binding domain2012
Process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5&#8242004
Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage dur2000